322 related articles for article (PubMed ID: 29126447)
1. Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).
Mahwish ; Saeed F; Arshad MS; Nisa MU; Nadeem MT; Arshad MU
Lipids Health Dis; 2017 Nov; 16(1):211. PubMed ID: 29126447
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
[TBL] [Abstract][Full Text] [Related]
3. Dietary supplementation of bitter gourd reduces the risk of hypercholesterolemia in cholesterol fed sprague dawley rats.
Naz R; Anjum FM; Butt MS; Mahr-Un-Nisa -
Pak J Pharm Sci; 2016 Sep; 29(5):1565-1570. PubMed ID: 27731813
[TBL] [Abstract][Full Text] [Related]
4. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
Krawinkel MB; Keding GB
Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
[TBL] [Abstract][Full Text] [Related]
5. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
Shetty AK; Kumar GS; Sambaiah K; Salimath PV
Plant Foods Hum Nutr; 2005 Sep; 60(3):109-12. PubMed ID: 16187012
[TBL] [Abstract][Full Text] [Related]
6. Momordica charantia fruit reduces plasma fructosamine whereas stems and leaves increase plasma insulin in adult mildly diabetic obese Göttingen Minipigs.
Koopmans SJ; Binnendijk G; Ledoux A; Choi YH; Mes JJ; Guan X; Molist F; Thị Minh TP; van der Wielen N
PLoS One; 2024; 19(3):e0298163. PubMed ID: 38498469
[TBL] [Abstract][Full Text] [Related]
7. Increase in the free radical scavenging capability of bitter gourd by a heat-drying process.
Wei L; Shaoyun W; Shutao L; Jianwu Z; Lijing K; Pingfan R
Food Funct; 2013 Dec; 4(12):1850-5. PubMed ID: 24192975
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic and hypolipidemic effects of Lactobacillus fermentum, fruit extracts of Syzygium cumini and Momordica charantia on diabetes induced mice.
Yousaf S; Hussain A; Rehman S; Aslam MS; Abbas Z
Pak J Pharm Sci; 2016 Sep; 29(5):1535-1540. PubMed ID: 27731809
[TBL] [Abstract][Full Text] [Related]
9. Momordica charantia and type 2 diabetes: from in vitro to human studies.
Habicht SD; Ludwig C; Yang RY; Krawinkel MB
Curr Diabetes Rev; 2014 Jan; 10(1):48-60. PubMed ID: 24295371
[TBL] [Abstract][Full Text] [Related]
10. Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats.
Uche-Nwachi EO; McEwen C
Afr J Tradit Complement Altern Med; 2009 Oct; 7(1):24-33. PubMed ID: 21304609
[TBL] [Abstract][Full Text] [Related]
11. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats.
Sridhar MG; Vinayagamoorthi R; Arul Suyambunathan V; Bobby Z; Selvaraj N
Br J Nutr; 2008 Apr; 99(4):806-12. PubMed ID: 17942003
[TBL] [Abstract][Full Text] [Related]
12. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
Abd El Sattar El Batran S; El-Gengaihi SE; El Shabrawy OA
J Ethnopharmacol; 2006 Nov; 108(2):236-42. PubMed ID: 16815658
[TBL] [Abstract][Full Text] [Related]
13. Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.
Kumar Shetty A; Suresh Kumar G; Veerayya Salimath P
Mol Nutr Food Res; 2005 Aug; 49(8):791-6. PubMed ID: 16007724
[TBL] [Abstract][Full Text] [Related]
14. Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells.
Chao CY; Huang CJ
J Biomed Sci; 2003; 10(6 Pt 2):782-91. PubMed ID: 14631118
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
Poovitha S; Parani M
BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
[TBL] [Abstract][Full Text] [Related]
16. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos.
Khan MF; Abutaha N; Nasr FA; Alqahtani AS; Noman OM; Wadaan MAM
BMC Complement Altern Med; 2019 Jul; 19(1):184. PubMed ID: 31340810
[TBL] [Abstract][Full Text] [Related]
17. Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits.
Singh N; Gupta M
Indian J Exp Biol; 2007 Dec; 45(12):1055-62. PubMed ID: 18254212
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
Kumar GS; Shetty AK; Salimath PV
J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
[TBL] [Abstract][Full Text] [Related]
20. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
